In this CME Outfitters Snack, expert faculty will discuss biomarker research findings presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference, review the identification and measurement of AD pathophysiology, examine a framework for evidencing biomarker profiles of AD, provide updates on prognostic performance and interpretation of biomarkers, and conduct a case-based discussion of clinical impacts and applications.
0.5
11/30/2023
Michelle M. Mielke
Michelle M. Mielke, PhD is Chair of the Department of Epidemiology and Prevention, Professor of Epidemiology, and Professor of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative diseases.
Michelle M. Mielke
Michelle M. Mielke, PhD is Chair of the Department of Epidemiology and Prevention, Professor of Epidemiology, and Professor of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative diseases. One focus of her research is understanding the utility of blood-based biomarkers for implementation at the population-level for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and related dementias. Dr. Mielke is PI of several NIH-funded clinical and epidemiological-based grants and has published over 400 manuscripts. She received the John R. Raymond Mentor Award from the Women Scholars Initiative and recently became a Fellow in the American Association for the Advancement of Science (AAAS), Section on Neuroscience.
Anna D. Burke
Dr. Burke is a board-certified geriatric psychiatrist, the Karsten Solheim Chair for Dementia, and the Director of the Alzheimer’s and Memory Disorders Division at Barrow Neurological Institute in Phoenix, AZ. She also currently directs the Department of Neuropsychiatry at Barrow Neurological Institute.
Anna D. Burke
(Moderator)
Dr. Burke is a board-certified geriatric psychiatrist, the Karsten Solheim Chair for Dementia, and the Director of the Alzheimer’s and Memory Disorders Division at Barrow Neurological Institute in Phoenix, AZ. She also currently directs the Department of Neuropsychiatry at Barrow Neurological Institute.
Barrow Neurological Institute is a world class neurological and neurosurgical institute with a mission to accept challenges, reject norms, and push boundaries. The Barrow Alzheimer’s and Memory Disorders Division is one of the leading clinical and research institutes in the world, championing research in neurodegenerative disorders.
Dr. Burke has worked extensively with patients and families suffering with neurodegenerative disorders including Alzheimer’s disease. Her area of expertise includes the diagnosis and management of cognitive disorders and the treatment of challenging behavioral and psychiatric disturbances that result from neurological conditions.
In addition to her clinical work, Dr. Burke has led the development of comprehensive multispecialty clinical care models focused on improving the quality of care for individuals with cognitive impairment and improving the diagnosis and management of Alzheimer’s and related dementias in the community.
She is a well-respected researcher having led over 100 clinical trials of investigational therapies for Alzheimer’s and related dementias and is a well-respected author and key opinion leader in the field
Please join an expert multidisciplinary faculty in a compelling live and on-demand webcast on how to effectively implement MREMS in clinical practice. As a bonus feature, you’ll also be able to participate in an engaging MREMS “Clinical Clues” Escape Room activity to further reinforce the importance of pregnancy planning and/or prevention when using mycophenolate in women of childbearing potential.
1.0
11/08/2023
6:30 pm
Miae Kim
Miae Kim, PharmD, MS, BCPS, received a master's degree in Clinical Pharmacy from Seoul National University in South Korea, then moved to the U.S. where she graduated Summa Cum Laude with high distinction from the University of Minnesota with a PharmD.
Miae Kim
Miae Kim, PharmD, MS, BCPS, received a master’s degree in Clinical Pharmacy from Seoul National University in South Korea, then moved to the U.S. where she graduated Summa Cum Laude with high distinction from the University of Minnesota with a PharmD. She completed her PGY-1 pharmacy practice training at Beth Israel Deaconess Medical Center, and did a PGY-2 training in solid organ transplant at Brigham and Women?s Hospital in Boston. Dr. Kim joined the Center for Advanced Heart Disease at Brigham and Women’s Hospital as a heart transplant/MCS pharmacy specialist in 2013, working in both the inpatient and outpatient settings. She attained board certification as a Pharmacotherapy Specialist in 2013. Dr. Kim’s current interests include cardiac transplant complications, antibody-mediated rejection, and cardiac allograft vasculopathy, and she has published in multiple peer-reviewed journals and textbooks and presented at local, national, and international transplant conferences.
In the first episode of this CMEOCast podcast series, Dr. Faulk and Dr. Renew will help learners to translate data into clinical practice regarding the differences between clinical assessment, qualitative assessment, and quantitative TOF monitoring and their efficacy in detecting residual neuromuscular blockade.
0.75
08/31/2023
Debra J. Faulk
Dr. Debra Faulk is an associate professor of pediatric anesthesiology and board-certified pediatric anesthesiologist. Her interests include sedation, simulation, pre-operative anxiety, and emergence agitation in kids.
Debra J. Faulk
Dr. Debra Faulk is an associate professor of pediatric anesthesiology and board-certified pediatric anesthesiologist. Her interests include sedation, simulation, pre-operative anxiety, and emergence agitation in kids. Dr. Faulk’s current research is in the monitoring of neuromuscular blockade in pediatric anesthesia, including studies looking a residual neuromuscular blockade as well as validation of objective EMG monitoring and their use for appropriate dosing of sugammadex in children.
J. Ross Renew
Ross Renew, MD, FASA, FASE, graduated from Clemson University (Chemistry, BS) and completed medical school at the University of South Carolina School of Medicine. Dr. Renew completed anesthesia residency at Mayo Clinic Florida and his fellowship in adult cardiothoracic anesthesiology at Mayo Clinic in Rochester, MN.
J. Ross Renew
Ross Renew, MD, FASA, FASE, graduated from Clemson University (Chemistry, BS) and completed medical school at the University of South Carolina School of Medicine. Dr. Renew completed anesthesia residency at Mayo Clinic Florida and his fellowship in adult cardiothoracic anesthesiology at Mayo Clinic in Rochester, MN. Dr. Renew then returned to Jacksonville and has worked on staff at Mayo Clinic Florida, where he is currently an Associate Professor of Anesthesiology. Dr. Renew serves as the Vice Chair of Research and Associate Program Director for the department’s residency program. His research interests involve neuromuscular blockade and monitoring, transesophageal echocardiography, and caring for the cardiac patient undergoing non-cardiac surgery.
Join our newsletter
Stay up to date on new CME Outfitters activities, breaking news, and important developments in medical education.